CGT
GSK icon

Capital Guardian Trust’s GSK GSK Stock Holding History

Capital Guardian Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,395
Closed -$232K – 343
2017
Q1 		$232K Buy
4,395
+586
+15% +$29.7K ﹤0.01% 311
2016
Q4 		$183K Buy
3,809
+142
+4% +$7.01K ﹤0.01% 345
2016
Q3 		$198K Hold
3,667
– – ﹤0.01% 323
2016
Q2 		$199K Sell
3,667
-40
-1% -$2.11K ﹤0.01% 323
2016
Q1 		$188K Buy
3,707
+640
+21% +$31.9K ﹤0.01% 330
2015
Q4 		$155K Sell
3,067
-28,160
-90% -$1.44M ﹤0.01% 359
2015
Q3 		$1.5M Buy
31,227
+2,597
+9% +$135K 0.01% 233
2015
Q2 		$1.49M Buy
28,630
+821
+3% +$46.2K 0.01% 234
2015
Q1 		$1.6M Buy
27,809
+19,153
+221% +$1.1M 0.01% 225
2014
Q4 		$462K Buy
8,656
+1,049
+14% +$58.7K ﹤0.01% 284
2014
Q3 		$437K Buy
7,607
+607
+9% +$37.2K ﹤0.01% 271
2014
Q2 		$468K Buy
7,000
+1,674
+31% +$113K ﹤0.01% 260
2014
Q1 		$356K Buy
5,326
+1,487
+39% +$101K ﹤0.01% 265
2013
Q4 		$256K Buy
3,839
+3,040
+380% +$197K ﹤0.01% 289
2013
Q3 		$50K Buy
+799
New +$51.4K ﹤0.01% 340

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Guardian Trust's GSK Position: Q2 2017 in Review

Capital Guardian Trust sold out of GSK (GSK) in Q2 2017, closing a stake of 4,395 shares — an estimated $232K sold.

Capital Guardian Trust first reported a position in GSK in Q3 2013 and held it in 15 quarters. The position peaked at $1.6M in Q1 2015. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Capital Guardian Trust reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • Capital Guardian Trust sold 4,395 GSK shares in Q2 2017, an estimated $232K.
  • Capital Guardian Trust first reported a position in GSK in Q3 2013 and held it in 15 quarters.
  • Capital Guardian Trust's GSK position peaked at $1.6M in Q1 2015.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Capital Guardian Trust's 13F filing for Q2 2017, filed 14 Aug 2017.